High Blood Pressure

Clinical Trial Finder

Many patients with high blood pressure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)

Condition:   Hypertension
Interventions:   Drug: Bisoprolol 2.5 mg;   Drug: Placebo
Sponsor:   Chinese University of Hong Kong
Recruiting - verified March 2015

Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension

Condition:   Pseudotumor Cerebri
Intervention:   Other: Radiological Imaging
Sponsor:   Anastasia Neufeld
Not yet recruiting - verified March 2015

Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)

Condition:   Hypertension
Interventions:   Device: Renal Denervation (Vessix);   Device: Renal Angiography
Sponsor:   Boston Scientific Corporation
Recruiting - verified March 2015

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)

Condition:   Hypertension
Intervention:  
Sponsor:   Boryung Pharmaceutical Co., Ltd
Recruiting - verified March 2014

Ventricular Reversed Remodeling After LTX in PAH Patients

Condition:   Pulmonary Arterial Hypertension
Intervention:  
Sponsors:   University Medical Centre Groningen;   VU University Medical Center
Recruiting - verified March 2015

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

Condition:   Hypertension
Interventions:   Drug: Fimasartan;   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Inje University
Recruiting - verified March 2015

Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products

Conditions:   Hypertension;   Prehypertension
Interventions:   Dietary Supplement: High fat dairy;   Dietary Supplement: Plant-based
Sponsor:   University of Texas at Austin
Not yet recruiting - verified March 2015

Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers

Condition:   Hypertension
Interventions:   Drug: Fimasartan;   Drug: Atorvastatin
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Seoul National University Hospital
Not yet recruiting - verified March 2015

Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)

Conditions:   Hypertension, Renovascular;   Renal Artery Stenosis;   Myocardial Infarction
Interventions:   Procedure: renal artery angiography;   Procedure: coronarography;   Procedure: coronary angioplasty;   Procedure: pulse wave velocity measurement;   Procedure: body composition monitoring
Sponsor:   Grigore T. Popa University of Medicine and Pharmacy
Recruiting - verified March 2015

Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

Condition:   Sickle Cell Disease
Interventions:   Other: Cardiac echography;   Other: Biological parameters;   Other: Clinical parameters
Sponsor:   Brugmann University Hospital
Recruiting - verified March 2015

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

Conditions:   Chronic Myeloid Leukemia;   Chronic Phase;   Adults
Intervention:   Drug: Ponatinib
Sponsor:   Gruppo Italiano Malattie EMatologiche dell'Adulto
Not yet recruiting - verified March 2015

Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension

Condition:   Hypertension
Interventions:   Dietary Supplement: BeneFlax®;   Behavioral: Walking training;   Behavioral: Flexibility training;   Dietary Supplement: Placebo (Whey Protein);   Behavioral: Dash Eating Plan
Sponsor:   University of Saskatchewan
Not yet recruiting - verified February 2015

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Rosuvastatin;   Drug: Telmisartan/Amlodipine;   Drug: Rosuvastatin and Telmisartan/Amlodipine
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed - verified March 2015

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Condition:   Glaucoma, Neovascular
Interventions:   Drug: Aflibercept (Eylea, BAY 86-5321);   Drug: Sham Injection
Sponsors:   Bayer;   Regeneron Pharmaceuticals
Not yet recruiting - verified March 2015

A Phase I Clinical Trial of DARC

Conditions:   Glaucoma;   Ocular Hypertension;   Glaucoma, Suspect
Intervention:   Drug: ANX776
Sponsors:   University College, London;   Wellcome Trust
Not yet recruiting - verified March 2015

Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease

Condition:   Renal Insufficiency, Chronic
Intervention:   Procedure: Hemodialysis
Sponsor:   University of Nove de Julho
Recruiting - verified March 2015

Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial

Condition:   Neonatal Encephalopathy
Intervention:   Device: Whole body cooling (Tecotherm)
Sponsors:   Thayyil, Sudhin;   Madras Medical College;   Manipal Hospital, India;   Indira Gandhi Medical College;   Sion Hospital, Mumbai;   Jawaharlal Institute of Postgraduate Medical Education & Research;   Calicut Medical College, Kerala;   Bill and Melinda Gates Foundation;   Imperial College London
Not yet recruiting - verified March 2015

Effects of a Physical Exercise Program on Microcirculation and Pregnancy Outcomes in Obese Pregnant Women

Conditions:   Obesity;   Pregnancy
Intervention:   Other: Physical exercise program
Sponsors:   Karine Ferreira Agra;   Professor Fernando Figueira Integral Medicine Institute;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Not yet recruiting - verified March 2015

Pre-Eclampsia And Growth Restriction: a Longitudinal Study

Conditions:   Preeclampsia;   Severe Preeclampsia;   Fetal Growth Restriction;   Preterm Birth
Intervention:  
Sponsors:   Centre Hospitalier Universitaire de Québec, CHU de Québec;   Jeanne-et-Jean-Louis-Lévesque Chair;   Laval University
Recruiting - verified March 2015

Trial of Vitamin D Supplements to Raise Calcidiol Levels of Pregnant Women in Mongolia

Conditions:   Pregnancy;   Vitamin D Deficiency
Interventions:   Dietary Supplement: 600 IU Vitamin D3 in prenatal vitamin;   Dietary Supplement: 2000 IU Vitamin D3 in prenatal vitamin;   Dietary Supplement: 4000 IU Vitamin D3 in prenatal vitamin
Sponsors:   Brigham and Women's Hospital;   National Center for Maternal and Child Health Research, Mongolia;   Zuun Kharaa Hospital, Selenge aimag. Mongolia
Recruiting - verified March 2015

A Multi-center Trial of IMPaCT CHW Support for Chronically-ill Patients

Conditions:   Hypertension;   Diabetes;   Obesity;   Tobacco Dependence
Intervention:   Behavioral: IMPaCT
Sponsors:   University of Pennsylvania;   Patient Centered Outcome Research Institute
Active, not recruiting - verified January 2015

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

Conditions:   Atrial Fibrillation;   Hypertension
Intervention:   Device: Screening: Intervention - Atrial fibrillation screening (ZIO XT ECG monitor, Watch-BP)
Sponsors:   Population Health Research Institute;   Canadian Stroke Prevention Intervention Network (C-SPIN);   Canadian Institutes of Health Research  (CIHR);   Heart and Stroke Foundation of Canada;   Canadian Stroke Network;   Boehringer Ingelheim;   iRhythm Technologies, Inc.;   Microlife
Not yet recruiting - verified March 2015

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Condition:   Hypertension
Interventions:   Drug: Felodipine tablet (Plendil) alone;   Drug: Felodipine tablet (Plendil)+Hydrochlorothiazide;   Drug: Felodipine tablet (Plendil)+Metoprolol tablet (Betaloc ZOK);   Drug: Felodipine tablets (Plendil)+Lisinopril (Zestril)
Sponsor:   AstraZeneca
Completed - verified March 2015

An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

Condition:   Hypertension
Intervention:  
Sponsors:   Abbott;   Monitor Medikal Araştırma ve Danışmanlık Tic.Ltd.Şti (MonitorCRO)
Recruiting - verified March 2015

Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

Conditions:   Hyperhomocysteinemia;   Hypertension Grade I
Intervention:   Dietary Supplement: Verum
Sponsors:   Dr. Loges & Co. GmbH;   BioTeSys GmbH
Recruiting - verified November 2014

Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

Condition:   Preeclampsia
Intervention:   Device: Apheresis for extracorporal removal of sFlt-1
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified March 2015

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

Condition:   PAH
Intervention:   Drug: oral treprostinil
Sponsor:   United Therapeutics
Recruiting - verified March 2015

A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Out Comes?

Condition:   Physician Education
Intervention:   Drug: Regorafenib (Stivarga, BAY 73-4506)
Sponsor:   Bayer
Recruiting - verified March 2015

Mobile Application to Improve Nutritional Counseling Provided by Primary Care Physicians for Hypertension.

Condition:   Hypertension
Interventions:   Other: telehealth;   Other: nutritional counseling;   Device: smartphone (mobile app)
Sponsors:   Hospital de Clinicas de Porto Alegre;   Federal University of Rio Grande do Sul
Completed - verified March 2015

Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

Conditions:   Hypertension;   Hypertension, Essential
Interventions:   Drug: Angiotensin (1-7);   Drug: Trimethaphan;   Drug: Phenylephrine
Sponsor:   Vanderbilt University
Recruiting - verified March 2015

Human Microbiota and Liver Transplant

Conditions:   Intestinal Microbiota;   Complication of Transplanted Liver;   Acute Rejection of Liver Transplant;   Infection
Intervention:  
Sponsor:   Hospital Vall d'Hebron
Recruiting - verified March 2015

Identify Possible Errors on Home Use Blood Pressure Monitors by Usability Reasoning

Condition:   Hypertension
Intervention:  
Sponsor:   National Taiwan University Hospital
Completed - verified March 2015

A Study of LY2623091 in Participants With High Blood Pressure

Condition:   Primary Hypertension
Interventions:   Drug: LY2623091;   Drug: Tadalafil;   Drug: Spironolactone;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Active, not recruiting - verified March 2015

Influence of Periodontal Diseases on Vascular Parameters in Patients Suffering of Hypertension

Conditions:   Chronic Periodontitis;   Hypertension
Intervention:   Other: echo Doppler lower limbs
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting - verified March 2015

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Conditions:   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Empagliflizon low dose;   Drug: placebo;   Drug: Empagliflizon high dose
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified March 2015

Diuretics for Postpartum High Blood Pressure in Preeclampsia

Condition:   Preeclampsia
Interventions:   Drug: FUROSEMIDE;   Drug: Placebo
Sponsor:   Instituto Materno Infantil Prof. Fernando Figueira
Active, not recruiting - verified March 2015

Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab

Conditions:   Colorectal Neoplasms;   Metastatic Disease
Intervention:   Drug: Regorafenib
Sponsors:   Spanish Cooperative Group for Digestive Tumour Therapy (TTD);   Bayer
Recruiting - verified March 2015

Assessment of Portal Hypertension Before Liver Resection in Patients With Hepatocellular Carcinoma

Condition:   Primary Liver Cancers
Intervention:  
Sponsor:   Henri Mondor University Hospital
Recruiting - verified March 2015

Abdominal Compression Elastic Support (ACES)

Condition:   Intradialytic Hypotension
Intervention:   Device: Abdominal Compression Elastic Support
Sponsors:   Global Monitors, Inc.;   University of Virginia
Recruiting - verified March 2015

Automated Administration of Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia

Condition:   Anesthesia
Intervention:   Device: Learning Intravenous Resuscitator (LIR) system
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Recruiting - verified March 2015

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (ADEMPAS, BAY63-2521)
Sponsor:   Bayer
Recruiting - verified March 2015

Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation, Renal Artery Denervation or Both.

Conditions:   Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation;   Hypertension
Intervention:   Procedure: procedure
Sponsor:   Diagram B.V.
Recruiting - verified March 2015

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat(BAY63-2521)
Sponsor:   Bayer
Recruiting - verified March 2015

Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A

Condition:   Healthy
Intervention:   Procedure: None, a blood draw
Sponsors:   University of Pennsylvania;   Eli Lilly and Company
Active, not recruiting - verified March 2014

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Condition:   Carotid Stenosis
Interventions:   Procedure: Carotid endarterectomy;   Device: Carotid stenting
Sponsors:   Thomas G. Brott, M.D.;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2015

Effect of Oligopin® on Blood Pressure.

Conditions:   Blood Pressure;   Hypertension
Interventions:   Dietary Supplement: Placebo;   Dietary Supplement: Oligopin®
Sponsor:   Technological Centre of Nutrition and Health, Spain
Completed - verified March 2015

Chest Wall Influence on Respiratory System Mechanics in Morbidly Obese Patients

Conditions:   Obesity;   Intra-Abdominal Hypertension
Intervention:   Other: Respiratory mechanics assessment
Sponsor:   Massachusetts General Hospital
Completed - verified March 2015

Role of Endothelin-1 in Flow-mediated Dilatation

Condition:   Healthy Conditions
Intervention:   Drug: BQ-788 and/or BQ-123
Sponsor:   University Hospital, Rouen
Completed - verified March 2015

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified March 2015

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Condition:   Hypertension
Interventions:   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106);   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106);   Drug: Candesartan Cilexetil;   Drug: Candesartan matching placebo;   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) 30/16mg matching placebo;   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Sponsor:   Bayer
Not yet recruiting - verified March 2015

Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor

Conditions:   Hypertension;   Atrial Fibrillation;   Obesity;   Heart Failure;   Atherosclerosis
Intervention:  
Sponsor:   Health Parametrics Inc.
Active, not recruiting - verified January 2014

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Condition:   Preeclampsia
Intervention:   Biological: Recombinant human antithrombin (ATryn)
Sponsor:   rEVO Biologics
Recruiting - verified March 2015

UAB Center of Research Translation (CORT) Project 2: The Effects of Urate Lowing Therapy (ULT) in Inflammation, Endothelial Function, and Blood Pressure

Conditions:   Pre-hypertension;   JNC 7 Stage I Hypertension
Interventions:   Drug: Allopurinol;   Drug: Placebo
Sponsors:   University of Alabama at Birmingham;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2015

Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.

Condition:   Castration-resistant Prostate Cancer
Interventions:   Drug: abiraterone acetate;   Drug: prednisone;   Procedure: pre-treatment and progression tumor biopsies;   Genetic: assessment of serum corticosteroid intermediates and ACTH
Sponsors:   Dana-Farber Cancer Institute;   Janssen Research & Development, LLC
Recruiting - verified March 2015

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (Adempas, BAY63-2521)
Sponsor:   Bayer
Recruiting - verified March 2015

Prevalence of Morbidity in Newly Diagnosed type2 Diabetes in Adults

Conditions:   Type2 Diabetes Mellitus;   Complications
Intervention:   Other: no specific treatment
Sponsors:   University of Algiers;   National Institute of public Health, Algeria;   Ain-Taya's hospital, Algiers;   Parnet's teaching Hospital, Algiers;   Mustapha Pacha's teaching hospital, Algiers;   Birtraria's teaching hospital, Algiers;   Bab el Oued's teaching hospital, Algiers
Completed - verified March 2015

Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia

Condition:   Hypertension
Interventions:   Drug: Ibuprofen;   Drug: Acetaminophen
Sponsor:   Complejo Hospitalario Dr. Arnulfo Arias Madrid
Completed - verified March 2015

Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review

Condition:   Gestational Diabetes Mellitus
Interventions:   Drug: Glyburide vs Insulin trials;   Drug: Metformin vs Insulin trials;   Drug: Metformin vs Glyburide trials
Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Completed - verified November 2013

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study

Conditions:   Glaucoma;   Ocular Hypertension
Interventions:   Drug: Preservative-free latanoprost;   Drug: Preservative-free bimatoprost
Sponsor:   Association for Innovation and Biomedical Research on Light and Image
Completed - verified April 2014

Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)

Condition:   Glaucoma, Angle-closure, Primary, Acute
Interventions:   Drug: QPI-1007 Injection;   Drug: (including placebo)
Sponsor:   Quark Pharmaceuticals
Active, not recruiting - verified March 2015

Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.

Conditions:   Diabetic Nephropathy;   Hypertension
Intervention:   Drug: Green tea extract
Sponsor:   University of Campinas, Brazil
Completed - verified August 2013

Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy

Condition:   Hypertension Secondary to Renal Disease
Intervention:   Procedure: Renal nerve denervation
Sponsors:   Turku University Hospital;   Oulu University Hospital;   Satakunta Central Hospital;   Central Finland Hospital District;   Vaasa Central Hospital, Vaasa, Finland
Recruiting - verified March 2015

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

Conditions:   Persistent Fetal Circulation Syndrome;   Hypertension, Pulmonary, of Newborn, Persistent;   Persistent Pulmonary Hypertension of Newborn
Interventions:   Drug: Inhaled nitric oxide;   Drug: Nitrogen Gas;   Drug: Crossover iNO
Sponsors:   University of Florida;   Ikaria
Not yet recruiting - verified March 2015

Closed-loop Fluid Administration System: Pilot Study to Evaluate Feasibility

Condition:   Anesthesia
Interventions:   Drug: Open loop;   Device: Closed-loop
Sponsor:   Hopital Foch
Terminated - verified December 2014

Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)

Conditions:   Cognitive Ability, General;   High Blood Pressure
Intervention:  
Sponsor:   Imperial College London
Active, not recruiting - verified May 2014

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

Conditions:   Colorectal Neoplasms;   Metastatic Disease
Intervention:   Drug: Regorafenib
Sponsors:   Spanish Cooperative Group for Digestive Tumour Therapy (TTD);   Bayer
Recruiting - verified March 2015

Standard 24-hour Urine Protein vs Shorter Period for Diagnosis of Pre-eclampsia

Condition:   Preeclampsia
Intervention:  
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified March 2015

Resveratrol and Cardiovascular Health in the Elderly

Conditions:   Vascular Resistance;   Aging;   Hypertension;   Antioxidants;   Aerobic Capacity
Interventions:   Dietary Supplement: Resveratrol;   Drug: Placebo
Sponsor:   National Institute on Aging (NIA)
Recruiting - verified December 2014

CO-OP Trial: Community-based Outreach on Obesity in Pregnancy

Conditions:   Obesity;   Pregnancy
Intervention:   Behavioral: Dietary counseling. Maintain a food diary.
Sponsors:   University of Missouri, Kansas City;   Truman Medical Center
Recruiting - verified March 2015

CPAP in SAHS Patients With Hypertension

Conditions:   Sleep Apnea Syndromes;   Hypertension
Interventions:   Device: CPAP nasal;   Device: sham CPAP nasal
Sponsor:   Hospital Universitario La Paz
Recruiting - verified March 2015

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Condition:   Hypertension, Pulmonary
Interventions:   Drug: Tadalafil;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2015

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

Condition:   Hypertension
Interventions:   Drug: Chlorthalidone 12.5 mg;   Drug: Hydrochlorothiazide 25 mg;   Drug: Placebo
Sponsor:   Creighton University
Withdrawn - verified March 2015

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Condition:   Kidney Transplantation
Interventions:   Drug: Belatacept;   Drug: Tacrolimus;   Drug: Cyclosporine
Sponsor:   Bristol-Myers Squibb
Recruiting - verified March 2015

Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma

Conditions:   Metastatic Colorectal Cancer;   Glioblastoma;   Bevacizumab;   Capillaroscopy
Interventions:   Other: capillaroscopy;   Other: blood pressure measurement
Sponsor:   Centre Georges Francois Leclerc
Recruiting - verified September 2014

Third Ventriculostomy Versus Shunt for Children With Hydrocephalus

Condition:   Communicating Hydrocephalus
Interventions:   Procedure: Endoscopic third ventriculostomy (ETV);   Procedure: Ventricular shunt
Sponsors:   Duke University;   Pediatric Hydrocephalus Foundation;   Children's Miracle Network Hospitals
Active, not recruiting - verified March 2015

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

Condition:   Pulmonary Arterial Hypertension
Intervention:  
Sponsor:   United Therapeutics
Completed - verified May 2014

Inflammation and Glycation in a General Adult Population

Condition:   Inflammation
Intervention:  
Sponsors:   Hospital Clinico Universitario de Santiago;   Medtronic
Recruiting - verified March 2015

The Six Minute Walk Test: Influence of Patient Effort on Results and Interpretation

Condition:   Each Patient Serves as His/Her Own Control.
Intervention:   Behavioral: alternative instruction in exercise testing (6MWT)
Sponsors:   Inova Health Care Services;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2015

A Randomized Cross-over Study for Normal Pressure Hydrocephalus

Condition:   Normal Pressure Hydrocephalus
Intervention:   Device: MIETHKE proGAV® / MIETHKE proSA®
Sponsors:   Johns Hopkins University;   Aesculap, Inc.;   Ohio State University;   Rhode Island Hospital;   Virginia Commonwealth University;   Henry Ford Health System
Recruiting - verified March 2015

A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

Conditions:   Sickle Cell Disease;   Sickle Cell Anemia
Intervention:   Drug: N-Acetylcysteine
Sponsors:   Puget Sound Blood Center;   University of Washington
Enrolling by invitation - verified March 2015

Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery

Conditions:   Pregnancy;   Severe Pre-eclampsia
Interventions:   Drug: Remifentanil;   Drug: Dexmedetomidine
Sponsor:   Mansoura University
Recruiting - verified March 2015

Blood Pressure Outcomes With Liraglutide Therapy

Conditions:   Type 2 Diabetes;   Systolic Hypertension
Interventions:   Drug: Liraglutide;   Drug: Placebo
Sponsors:   Mount Sinai Hospital, Canada;   Novo Nordisk A/S
Completed - verified March 2015

DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial

Condition:   Improve Healthy Ageing in Seniors; Prevent Disease at Older Age
Interventions:   Drug: Vitamin D3;   Drug: Omega 3 fatty acids;   Procedure: Strength Home Exercise;   Procedure: Flexibility Home Exercise
Sponsors:   University of Zurich;   Recruitment Partners;   University of Zurich, Switzerland (Prof. Heike A. Bischoff-Ferrari, MD DrPH);   University of Geneva, Switzerland (Prof. René Rizzoli, MD);   University of Basel, Switzerland (Prof. Reto W. Kressig, MD and PD Norbert Suhm, MD);   University Hospital, Toulouse, France (Prof. Bruno Vellas, MD);   Charite University, Berlin, Germany;   Medical University Innsbruck;   University of Coimbra, Portugal (Prof. José daSilva, MD);   Other University Partners;   University of Sheffield;   University of Manchester, UK (Prof. David Felson, MD MPH);   Max Rubner University, Germany (Prof. Bernhard Watzl, PhD);   Technische Universität Dresden;   Centre on Aging and Mobility, University of Zurich (Prof. Andreas Maetzel, MD PhD);   Impact Partner;   International Osteoporosis Foundation (IOF; Prof. John Kanis, MD);   SME Partners;   Ferrari Data Solutions GmBH, Switzerland (Stephen M. Ferrari; direct data entry platform);   Gut Pictures, Switzerland (Benno Gut; animated exercise video);   NOVAMEN, France (Sandrine Rival; logistic management partner);   Pharmalys, UK (Marieme Ba; monitoring partner);   Industry Partners;   DSM Nutritional Products (Dr. Elisabeth Stöcklin PhD, Dr. Manfred Eggersdorfer PhD);   Nestlé (Michaela Höhne PhD, Irène Corthesy PhD);   Roche-Diagnostics (Monika Reuschling);   Funding within Framework 7 research program of the European Commission (project 278588);   Further collaborators and advisors at website do-health.eu
Active, not recruiting - verified March 2015

Effect of Local Anesthetic on Hemodynamic Measures During Nasal Surgery

Conditions:   Heart Rate;   Blood Pressure;   Blood Loss During Surgery;   Surgical Field
Intervention:  
Sponsor:   Loma Linda University
Withdrawn - verified March 2015

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Conditions:   Hepatitis C;   Cirrhosis;   Portal Hypertension;   With or Without Liver Decompensation
Interventions:   Drug: Sofosbuvir;   Drug: Ribavirin
Sponsor:   Gilead Sciences
Active, not recruiting - verified March 2015

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

Condition:   Salt-sensitive Hypertension
Interventions:   Drug: Valsartan;   Drug: LCZ696
Sponsor:   Novartis Pharmaceuticals
Completed - verified March 2015

Pharmacokinetics of Sildenafil in Premature Infants

Condition:   Persistent Pulmonary Hypertension of the Newborn
Intervention:   Drug: 1 dose of sildenafil
Sponsors:   University of North Carolina, Chapel Hill;   Duke University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The EMMES Corporation
Recruiting - verified March 2015

Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

Condition:   Kidney Transplantation
Intervention:   Drug: Everolimus
Sponsors:   Hospital do Rim e Hipertensão;   Novartis
Active, not recruiting - verified March 2015

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

Conditions:   Pulmonary Arterial Hypertension;   Hypertension, Pulmonary
Intervention:   Drug: Sildenafil
Sponsor:   Pfizer
Recruiting - verified March 2015

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

Conditions:   Type 2 Diabetes;   Chronic Kidney Disease
Interventions:   Drug: Dulaglutide;   Drug: Insulin glargine;   Drug: Insulin lispro
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2015

Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

Condition:   Intracerebral Hemorrhage
Intervention:   Other: Pet AV-45
Sponsors:   University Hospital, Toulouse;   Avid Radiopharmaceuticals;   Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified November 2014

Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome

Conditions:   Metabolic Syndrome;   Dyslipidemia;   Hypertriglyceridemia
Interventions:   Other: Standard reference diet;   Other: Almond supplemented diet;   Other: Low carbohydrate reference diet
Sponsors:   Children's Hospital & Research Center Oakland;   Almond Board of California
Recruiting - verified March 2015

Comparison of Two Techniques in Achieving Corneal Graft

Condition:   Fuch's Endothelial Dystrophy
Interventions:   Procedure: Endothelial descemet membrane graft;   Procedure: Endothelial descemet membrane graft
Sponsor:   University Hospital, Rouen
Recruiting - verified March 2015

An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: UT-15C (treprostinil diethanolamine)
Sponsor:   United Therapeutics
Recruiting - verified March 2015

Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: UT-15C (treprostinil diethanolamine);   Drug: Placebo
Sponsor:   United Therapeutics
Recruiting - verified March 2015

Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases

Conditions:   Retinal Dystrophies;   Age-related Macular Degeneration;   Arterial Hypertension;   Diabetes;   Traumatic Retinopathy;   Toxic Retinopathies
Intervention:  
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2015

Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery

Condition:   Primary Open Angle Glaucoma
Interventions:   Device: Hydrus Aqueous Implant;   Procedure: Cataract surgery
Sponsor:   Ivantis, Inc.
Recruiting - verified March 2015

ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations

Condition:   Chronic Venous Hypertension With Ulcer
Intervention:   Device: ActiVAC System + Compression therapy
Sponsor:   Georgetown University
Terminated - verified March 2015

Remodulin® to Oral Treprostinil Transition

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: UT-15C SR
Sponsor:   United Therapeutics
Completed - verified March 2015

R-21 Colorectal Cancer Screening (CRCS) Pilot Trial

Condition:   Colorectal Neoplasms
Interventions:   Behavioral: CRCS patient decision aid (PtDA) video;   Behavioral: Questionnaires;   Behavioral: Essential Hypertension video
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Recruiting - verified March 2015

BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the HOTMAN® sYstem

Condition:   Hypertension
Interventions:   Device: Integrated hemodynamic management (IHM) - HOTMAN System;   Device: Non Integrated Hemodynamic Management (Non-IHM) - HOTMAN System
Sponsor:   Hemo Sapiens, Inc.
Completed - verified November 2011

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Iloprost (Ventavis inhaled, BAYQ6256)
Sponsor:   Bayer
Active, not recruiting - verified March 2015

Identification of Risk Factors of Prolonged Wound Healing Following Primary Arthroplasty

Condition:   Evaluate Surgical, Medical and Pharmacological Factors Influence on Wound Healing Following Primary Arthroplasty Surgery
Intervention:  
Sponsor:   Hvidovre University Hospital
Recruiting - verified March 2015

Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction

Condition:   Renal Insufficiency
Intervention:   Drug: ATeGe-Fresenius
Sponsors:   Hospital Vall d'Hebron;   Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified March 2015

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension

Conditions:   Tourniquet-induced Pain;   Tourniquet-induced Hypertension
Interventions:   Drug: gabapentin 600 mg po;   Drug: Placebo pill given one hour before surgery
Sponsor:   Baylor College of Medicine
Withdrawn - verified March 2015

Mifepristone for Metabolic Syndrome

Conditions:   Endocrine Disease;   Diabetes
Intervention:   Drug: Mifepristone
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2015

Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis

Conditions:   Compensated Cirrhosis;   Obesity
Intervention:   Behavioral: Diet + exercise
Sponsors:   Hospital Clinic of Barcelona;   Centro de Investigación Biomédica en Red
Completed - verified March 2015

Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals

Conditions:   Cardiovascular Disease;   Dyslipidemia;   Blood Pressure
Interventions:   Other: Dietary Intervention;   Other: Dietary Intervention;   Other: Dietary Intervention
Sponsors:   Children's Hospital & Research Center Oakland;   Dairy Management Inc.
Completed - verified March 2015

Pulmonary Hypertension Institutional Registry

Condition:   Death
Intervention:  
Sponsor:   Hospital Italiano de Buenos Aires
Recruiting - verified March 2015

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Ambrisentan
Sponsor:   GlaxoSmithKline
Recruiting - verified March 2015

Efficacy and Safety of Ambrisentan in Children 8-18yrs

Condition:   Hypertension, Pulmonary
Interventions:   Drug: Ambrisentan - low dose;   Drug: Ambrisentan - high dose
Sponsor:   GlaxoSmithKline
Suspended - verified March 2015

Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

Conditions:   Hypertension;   Pure Autonomic Failure;   Multiple System Atrophy
Interventions:   Drug: Losartan;   Drug: Captopril;   Drug: Placebo
Sponsor:   Vanderbilt University
Recruiting - verified March 2015

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: inhaled prostacyclin;   Drug: inhaled prostacyclin;   Drug: prostacyclin;   Drug: subcutaneous and intravenous prostacyclin;   Drug: oral ERA;   Drug: oral PDE5 inhibitors
Sponsor:   United Therapeutics
Completed - verified March 2015

Long-Term Non-Interventional Latanoprost Study

Conditions:   Glaucoma;   Ocular Hypertension
Interventions:   Other: No intervention other than routine medical care;   Other: No intervention other than routine medical care
Sponsor:   Pfizer
Active, not recruiting - verified March 2015

The Study of Ocular Hemodynamics With Glaucoma Progression

Condition:   Glaucoma
Intervention:  
Sponsor:   Indiana University
Active, not recruiting - verified March 2015

AMG 102 and Avastin for Recurrent Malignant Glioma

Conditions:   Glioblastoma Multiforme;   Gliosarcoma
Interventions:   Drug: AMG 102;   Drug: Avastin
Sponsors:   Katy Peters;   Amgen
Active, not recruiting - verified March 2015

Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding

Conditions:   Cirrhosis;   Hypertension, Portal;   Bleeding Esophageal Varices;   Portal Vein Thrombosis
Interventions:   Drug: Simvastatin;   Drug: Placebo
Sponsor:   Juan A. Arnaiz
Completed - verified March 2015

Coenzyme Q-10 and Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Dietary Supplement: Coenzyme Q-10 in Pulmonary Hypertension subjects;   Dietary Supplement: Coenzyme Q-10 in Normal Control subjects
Sponsor:   The Cleveland Clinic
Completed - verified March 2015

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 (8266-002)(COMPLETED)

Condition:   Hypertension
Interventions:   Drug: MK8226 1 mg QD;   Drug: MK8266 2 mg QD;   Drug: MK8266 4 mg QD;   Drug: MK8266 4 mg BID;   Drug: MK8266 4 mg TID;   Drug: Comparator: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2015

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified March 2015

Cozaar XQ Re-examination Study (MK-0954-349)

Condition:   Hypertension
Intervention:   Drug: amlodipine/losartan
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2015

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Condition:   Myasthenia Gravis
Intervention:   Drug: Prednisone - Azathioprine
Sponsor:   Assistance Publique - Hôpitaux de Paris
Active, not recruiting - verified June 2012

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Telmisartan 80 mg/d;   Drug: Ramipril 10 mg/d
Sponsor:   University of Erlangen-Nürnberg Medical School
Completed - verified March 2015

Sympathetic Nerve Activity in Renal Failure

Conditions:   Chronic Kidney Disease;   Hypertension
Interventions:   Drug: Rilmenidine;   Drug: Nitrendipine
Sponsor:   University of Erlangen-Nürnberg Medical School
Withdrawn - verified March 2015

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

Conditions:   Chronic Kidney Disease;   Hyperphosphatemia
Interventions:   Drug: Sevelamer carbonate;   Drug: Placebo for sevelamer carbonate
Sponsor:   Genzyme, a Sanofi Company
Terminated - verified March 2015

Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

Condition:   HELLP Syndrome
Interventions:   Drug: dexamethasone;   Drug: Placebo;   Drug: dexamethasone
Sponsor:   Instituto Materno Infantil Prof. Fernando Figueira
Active, not recruiting - verified March 2015

A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure

Condition:   Hypertension
Interventions:   Device: Home monitoring;   Other: monitor & phone call
Sponsor:   George Washington University
Active, not recruiting - verified April 2008

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Conditions:   Gastrinoma;   Glucagonoma;   Insulinoma;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Pheochromocytoma;   Pancreatic Polypeptide Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Melanoma;   Recurrent Neuroendocrine Carcinoma of the Skin;   Recurrent Non-small Cell Lung Cancer;   Recurrent Pheochromocytoma;   Recurrent Renal Cell Cancer;   Somatostatinoma;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage IV Melanoma;   Stage IV Non-small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions:   Drug: everolimus;   Drug: vatalanib;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: ultrasound imaging
Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
Active, not recruiting - verified March 2015

Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus

Condition:   Diabetes
Intervention:   Other: Cocoa
Sponsors:   Brigham and Women's Hospital;   MasterFoods
Completed - verified March 2015

Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

Condition:   Chronic Obstructive Lung Disease
Intervention:   Drug: Tadalafil
Sponsor:   Herlev Hospital
Withdrawn - verified July 2007

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Condition:   Chronic Kidney Disease
Interventions:   Drug: Sevelamer hydrochloride;   Drug: Calcium-based phosphate binder
Sponsor:   Genzyme, a Sanofi Company
Completed - verified March 2015

HALT Progression of Polycystic Kidney Disease (HALT PKD) Study A

Condition:   Kidney, Polycystic
Interventions:   Drug: Lisinopril;   Drug: Telmisartan;   Drug: Placebo;   Other: Standard Blood Pressure Control;   Other: Low Blood Pressure Control
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Boehringer Ingelheim;   Merck Sharp & Dohme Corp.;   Polycystic Kidney Disease Foundation
Completed - verified March 2015

Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:   Behavioral: Patient-centered Counseling
Sponsors:   Boston Medical Center;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified August 2014

Ontario Printed Educational Materials (PEMs) for Physician Behaviour Change

Conditions:   Education, Medical, Continuing;   Practice Patterns;   Hypertension;   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Printed Educational Message
Sponsor:   Institute for Clinical Evaluative Sciences
Active, not recruiting - verified March 2015

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

Condition:   High Blood Pressure
Interventions:   Drug: losartan potassium;   Drug: Comparator: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2015

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Condition:   Hypertension
Interventions:   Drug: MK0954A, hydrochlorothiazide (+) losartan potassium;   Drug: Comparator: placebo, losartan, hydrochlorothiazide
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2015

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

Condition:   Pulmonary Hypertension
Intervention:   Drug: UT-15
Sponsor:   United Therapeutics
Completed - verified September 1999

Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia

Condition:   Pre-eclampsia
Interventions:   Drug: magnesium sulfate;   Drug: nimodipine
Sponsors:   FDA Office of Orphan Products Development;   University of Utah
Completed - verified January 2001

Get CardioSmart

You're Invited